skip to main content

Funding Opportunities

Newly Posted Opportunities:

Submit by April 1, 2019

    Sponsor: American Cancer Society (ACS)
    Title: Physician Training Awards in Cancer Prevention
    Award: $300,000
    Link: https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/physician-training-awards.html
    Awards to support physician training in accredited preventive medicine residency programs that provide cancer prevention and control research and practice opportunities.

    Sponsor: B*CURED
    Title: Brain Cancer Research Investigator Grant
    Award: $50,000
    Link: http://bcured.org/grants/
    For investigators whose primary focus is brain cancer research. Clinical projects are encouraged, as well as translational projects with significant clinical promise. Projects for adult and pediatric brain cancer research will be considered.

Submit by June 19, 2019

    Sponsor: National Institutes of Health (NIH)
    Title: Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20) [RFA-CA-19-034]
    Award: $2,400,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-034.html
    The P20 grants will support feasibility and planning activities to build comprehensive cancer health disparities research programs. All applications must propose translational research that will contribute to improved prevention, early detection, diagnosis, and/or treatment of cancers found to disproportionately affect specific racial/ethnic minority populations. Furthermore, all research projects must be focused upon knowledge of human biology with a translational human endpoint proposed.

Rogel Cancer Funds (submit monthly):

Questions? Contact: Kristin Van Raaphorst kvanraap@med.umich.edu

Recently Announced

Submit by March 22, 2019: National Institute of Health (NIH)

    Title: HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed) [RFA-EB-18-003]]
    Award: $6,750,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-19-003.html
    Treatment using credible neural targets for device-based interventions and/or diagnostics for pain, building upon the latest mechanistic knowledge about the anatomy and physiology of central, spinal, and peripheral pathways involved in pain. Objective: the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. (NCI participating).

    Title: HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) [RFA-NS-19-016]
    Award:Application budgets are not limited but need to reflect the actual needs of the proposed project (standard)
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-016.html
    Activities supported include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, as well as a subsequent small clinical trial (e.g., Early Feasibility Study). (NCI participating)

    Title: HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional) [RFA-NS-19-018]
    Award:Application budgets are not limited but need to reflect the actual needs of the proposed project (standard)
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-018.html
    Encourages investigators to pursue a small clinical trial to obtain critical information necessary to advance recording and/or stimulating devices to treat pain with innovative, targeted, and non-addictive diagnostic and/or therapeutic devices that improve patient outcomes and decrease or eliminate the need to prescribe opioids. (NCI participating)

Submit by March 22, 2019 to National Comprehensive Cancer Network (NCCN) and Eli Lilly

    Title: Preclinical and Clinical Studies of CDK4 and 6 Inhibition with Abemaciclib for Breast Cancers
    Award: $500,000
    Link: http://www.nccn.org/clinical_trials/investigators/default.asp
    The overall aim is to develop innovative studies to help determine the role of abemaciclib in the treatment of breast cancer. Proposals (which can be preclinical, phase I/II clinical trials or correlative trials) submitted in response to this RFP will be useful in guiding further development of abemaciclib.

Submit by March 26 to the NIH

    Title: Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) [RFA-CA-19-033]
    Award: $2,500,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-033.html
    The purpose is to stimulate the development, testing, and/or scaling of innovative, feasible, and effective interventions to address adverse physical and psychosocial effects in survivors of pediatric and/or adolescent/young adult (AYA) cancer. These interventions may be targeted to the patient or to the patient-caregiver dyad, and may include multilevel interventions delivered by providers, teams, communities, and/or care delivery systems.

Submit by March 26, 2019

LIMITED SUBMISSION

    Sponsor: V Foundation
    Title: Translational Research Grant 2019
    Award: $600,000
    Link: https://umms.infoready4.com/#competitionDetail/1785580
    The V Foundation Translational Research Grant Program seeks to support translational research projects within the scope of adult cancer research. Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years.

Submit by March 29, 2019

LIMITED SUBMISSION

    Sponsor: NIH
    Title: P30 Administrative Supplement: Activities to Promote Human Immune-Representing Oncology Models
    Award: $125,000
    Link: https://umms.infoready4.com/#competitionDetail/1785754
    NCI invites applications for administrative supplements to advance either an in vivo or in vitro model system to more closely recapitulate aspects of the human immune system in the context of the tumor microenvironment, in a manner that directly supports immuno-oncology research. Specifically, the NCI seeks to support projects that replace the use of human fetal tissue to model the tumor microenvironment with a more faithful representation of the human immune system.

Submit by April 1, 2019 to the American Cancer Society

Submit by April 1, 2019/h3>

    Sponsor: Cancer Research Institute
    Title: CRI Irvington Postdoctoral Fellowship Program
    Award: $175,500
    Link: http://www.cancerresearch.org/scientists/fellowships-grants/post-doctoral-fellows
    The Institute seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology. The applicant and sponsor should make every effort to demonstrate the potential of the proposed studies to directly impact our understanding of the immune system's role in cancer.

Sponsor: B*CURED
Title: Brain Cancer Research Investigator Grant
Award: $50,000
Link: http://bcured.org/grants/
For investigators whose primary focus is brain cancer research. Clinical projects are encouraged, as well as translational projects with significant clinical promise. Projects for adult and pediatric brain cancer research will be considered.

Submit by April 4, 2019 to the ROGEL CANCER CENTER

    Title: Cancer Control and Population Studies Call for Proposals (general)
    Award: $50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785446
    This RFP is to develop and support new research projects that are broadly aligned with the mission of the cancer control and population sciences research program. Projects can span across a diverse range of topics that aim to reduce cancer risk, incidence, and cancer mortality and enhance quality of life for cancer survivors by supporting innovative research and recommending ways to apply that research in quality health care delivery. The projects can also be related to new data collection and methods development relevant to the CCPS research mission.

    Title: Cancer Control: Big Data and Cancer
    Award:$50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785441
    Proposed projects should lead to development of methods and algorithms that address current limitations in analyzing Cancer Big Data and have relevance to the mission of Cancer Control and Population Sciences Research program.

    Title: CCPS Career Development
    Award:$50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785443
    The purpose of this RFP is to build capacity for junior investigators to develop federally-funded research programs with a focus in cancer control and population sciences. An explicit goal is to boost the number of faculty with funded R-level grants focused on cancer control and population science.

    Title: CCPS Oncology Survivorship Research “O-Sure”
    Award:$50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785444
    This RFP is to assist new collaborative research projects aimed at: 1) building capacity for cancer survivorship research, 2) addressing important gaps in cancer survivorship research and 3) fostering collaboration across programs. For the purpose of this RFA, cancer survivorship is being defined as the period of time after primary treatment (ie: post-chemotherapy, radiation therapy, surgery).

    Title: CCPS C-Cubed (Cancer Care and Control)
    Award: $50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785437
    Priority will be given to projects believed to have a high probability of external funding in the future, and that foster collaboration between investigators who have never worked together as a team and in particular collaborations between the two Rogel Cancer Center Population Science Programs, namely the Cancer Epidemiology and Prevention Program and the Health Behavior and Outcomes Program.

    Title: CCPS Outreach & Health Disparities
    Award: $50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785439
    This RFP is to develop and support new collaborative research projects addressing one or both of the following: 1) increasing engagement in research of underrepresented racial, ethnic and socio-economic minority patients in the University of Michigan Rogel Cancer Center and the Rogel Cancer Center's catchment area; and 2) developing sustainable approaches to ameliorate and eliminate health disparities in cancer care and outcomes.

Submit by April 8, 2019 to NIH

    Title: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31) [PA-18-666]
    Award: Stipends, tuition and fees, and institutional allowance. [standard]
    Link: https://grants.nih.gov/grants/guide/pa-files/PA-18-666.html
    The purpose is to provide support for mentored research training leading to the PhD or equivalent research degree, the combined MD/PhD degree, or another formally combined health professional degree and research doctoral degree in the biomedical, behavioral, or clinical sciences for individuals from diverse population groups.

    Title: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) [PA-19-187]
    Award: Stipend, tuition and fees, and institutional allowance
    Link: https://grants.nih.gov/grants/guide/pa-files/PA-19-187.html
    Individual fellowships for senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers.

    Title: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) [PA-19-188]
    Award: Stipend, tuition and fees, and institutional allowance
    Link: https://grants.nih.gov/grants/guide/pa-files/PA-19-188.html
    The F32 is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers. Applications are expected to incorporate exceptional mentorship.

    Title: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) [PA-19-191]
    Award: Stipend, tuition and fees, and institutional allowance
    Link: https://grants.nih.gov/grants/guide/pa-files/PA-19-191.html
    The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program, and who intend careers as physician/clinician-scientists. Applicants must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers.

    Title: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) [PA-19-195]
    Award: Stipend, tuition and fees, and institutional allowance
    Link: https://grants.nih.gov/grants/guide/pa-files/PA-19-195.html
    The purpose of the F31 award is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers.

    Title: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31) [PA-19-196]
    Award: Stipend, tuition and fees, and institutional allowance
    Link: https://grants.nih.gov/grants/guide/pa-files/PA-19-196.html
    The purpose of this F31 Fellowship to Promote Diversity in Health-Related Research award is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from diverse backgrounds including those from groups that are underrepresented in the biomedical, behavioral, or clinical research workforce.

Submit by April 4, 2019 to the ROGEL CANCER CENTER

    Title: Cancer Control and Population Studies Call for Proposals (general)
    Award: $50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785446
    This RFP is to develop and support new research projects that are broadly aligned with the mission of the cancer control and population sciences research program. Projects can span across a diverse range of topics that aim to reduce cancer risk, incidence, and cancer mortality and enhance quality of life for cancer survivors by supporting innovative research and recommending ways to apply that research in quality health care delivery. The projects can also be related to new data collection and methods development relevant to the CCPS research mission.

    Title: Cancer Control: Big Data and Cancer
    Award:$50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785441
    Proposed projects should lead to development of methods and algorithms that address current limitations in analyzing Cancer Big Data and have relevance to the mission of Cancer Control and Population Sciences Research program.

    Title: CCPS Career Development
    Award:$50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785443
    The purpose of this RFP is to build capacity for junior investigators to develop federally-funded research programs with a focus in cancer control and population sciences. An explicit goal is to boost the number of faculty with funded R-level grants focused on cancer control and population science.

    Title: CCPS Oncology Survivorship Research “O-Sure”
    Award:$50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785444
    This RFP is to assist new collaborative research projects aimed at: 1) building capacity for cancer survivorship research, 2) addressing important gaps in cancer survivorship research and 3) fostering collaboration across programs. For the purpose of this RFA, cancer survivorship is being defined as the period of time after primary treatment (ie: post-chemotherapy, radiation therapy, surgery).

    Title: CCPS C-Cubed (Cancer Care and Control)
    Award: $50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785437
    Priority will be given to projects believed to have a high probability of external funding in the future, and that foster collaboration between investigators who have never worked together as a team and in particular collaborations between the two Rogel Cancer Center Population Science Programs, namely the Cancer Epidemiology and Prevention Program and the Health Behavior and Outcomes Program.

    Title: CCPS Outreach & Health Disparities
    Award: $50,000
    Link: https://umms.infoready4.com/#competitionDetail/1785439
    This RFP is to develop and support new collaborative research projects addressing one or both of the following: 1) increasing engagement in research of underrepresented racial, ethnic and socio-economic minority patients in the University of Michigan Rogel Cancer Center and the Rogel Cancer Center's catchment area; and 2) developing sustainable approaches to ameliorate and eliminate health disparities in cancer care and outcomes.

Submit by April 23, 2019 to the DoD

    Title: Ovarian Cancer Pilot Award
    Award: $250,000
    Link: https://www.grants.gov/web/grants/view-opportunity.html?oppId=313164
    This award supports the exploration of innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. The proposed research must demonstrate a clear focus on ovarian cancer (e.g., using tissues, cell lines, datasets, or appropriate animal models). The proposed research should include a testable hypothesis based on strong scientific rationale and serve as a catalyst to expand or modify current thinking about and/or approaches in ovarian cancer.

    Title: Ovarian Cancer Investigator-Initiated Research Award
    Award: $450,000
    Link: https://www.grants.gov/web/grants/view-opportunity.html?oppId=313163
    This award is intended to support high-impact research that has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project.

Submit by April 25, 2019

    Sponsor: Memorial Sloan Kettering Cancer Center
    Title: Paul Marks Prize for Cancer Research
    Award: $150,000
    Link: https://www.mskcc.org/research-advantage/impact/paul-marks-prize-research
    The prize is intended to encourage young investigators who have a unique opportunity to help shape the future of cancer research. This prize is awarded to up to three investigators every other year. Nominees are required to be age 45 or younger on the date of the submission deadline. Each receives a medal and they share a cash award of $150,000.

    Sponsor: NIH
    Title: Advancing Cancer Immunotherapy by Mitigating Immune-Related Adverse Events (irAE) (U01 Clinical Trial Not Allowed) [RFA-CA-19-044]
    Award: $1,875,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-044.html
    This FOA is to support improved cancer immunotherapy research projects that reduce the incidence and/or severity of immune-related adverse events (irAEs) while retaining anti-tumor efficacy. Single investigators and/or multidisciplinary teams with expertise in mechanisms of cancer immunology, immune tolerance, irAEs, autoimmunity, and/or patient characterization and selection are encouraged.

Submit by April 30, 2019

    Sponsor: Centers for Disease Control and Prevention (CDC)
    Title: Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients
    Award: $360,000-1,800,000
    Link: https://www.grants.gov/web/grants/view-opportunity.html?oppId=310243
    This opportunity is intended to increase the availability of supportive services for young breast cancer survivors (YBCS), young women with metastatic breast cancer (mBC), and their caregivers and families by supporting organizations and entities that serve this population. To this end, activities funded by this opportunity are intended to support organizations in closing the disparity gap needed to support young breast cancer survivors by implementing strategies that aim to reduce disparities observed in survival and quality of life due to race, ethnicity, or other social determinants of health.

    Sponsor: DoD
    Title: Ovarian Cancer Academy - Early Career Investigator Award
    Award: $725,000
    Link: https://www.grants.gov/web/grants/view-opportunity.html?oppId=313160
    The OCRP Ovarian Cancer Academy Award mechanism is a unique, interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The overarching goal of the Ovarian Cancer Academy (OCA) is to develop successful, highly productive ovarian cancer researchers in a collaborative research and career development environment.

    Title: Ovarian Cancer Academy Dean and Assistant Dean (Leadership) Award
    Award: $1,750,000
    Link: https://www.grants.gov/web/grants/view-opportunity.html?oppId=313165
    This FY19 Funding Opportunity is soliciting applications for an Academy Dean and Assistant Dean to lead the OCA for an anticipated start date in first quarter of FY20 – exact date to be determined. The Academy Dean and Assistant Dean (referred to as Academy Leadership) must be established ovarian cancer researchers, and can be at different institutions.

    Sponsor: DoD
    Title: Ovarian Cancer Clinical Development Award
    Award: $800,000
    Link: https://www.grants.gov/web/grants/view-opportunity.html?oppId=313362
    The goal of this award mechanism is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected. Proof of concept demonstrating the potential utility of the proposed product or a prototype/ preliminary version of the proposed product should already be established.

Submit by May 1, 2019 to the ROGEL CANCER CENTER

    Title: Breast Oncology RFA for Lobular Breast Cancer and Other Areas of Breast Cancer Research
    Award: $100,000
    Link: https://umms.infoready4.com/#competitionDetail/1785500
    Studies can be laboratory, translational, or clinical studies, but must be focused on one of these topics: 1) The biology or clinical behavior, evaluation, and/or treatment of lobular breast cancer; 2) The function and/or clinical impact of genes associated with hereditary breast cancer in special underserved populations in cancer genetics, including but not restricted to: African Americans, LatinX, Africans, and south east Asians (Indian sub-continent and island states). If you include a different population, you must make the case that they are underserved in clinical cancer genetics; 3) Other areas specifically related cause, biology, evaluation, or treatment of breast cancer.

Submit by May 2, 2019 to the ROGEL CANCER CENTER

    Title: Innovation Grant
    Award: $150,000
    Link: https://umms.infoready4.com/#competitionDetail/1784698
    Planned new collaborative cancer grant submissions that are eligible for support from the Cancer Research Innovation Grant Program are geared to the following outcomes: I) Program project-type applications (e.g., NIH P01 or SPORE applications) in which Rogel Cancer Center members from two or more CCSG programs will serve as project leaders or co-investigators; II) Multi-disciplinary R01-type applications led by two or more Rogel investigators who do not presently hold a funded collaborative R01-type grant in the proposed research area. Investigators whose research grant application will emphasize translational and/or clinical research are strongly encouraged to apply.

Submit by May 23, 2019 to BCA

    Limited Submission

    Title: Young Investigator Grants
    Award: $125,000
    Link: https://umms.infoready4.com/#competitionDetail/1782501
    To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists whose primary focus is breast cancer and who are in the early stages of their careers, to apply for funding for the Young Investigator Grant.

Submit by June 4, 2019

    Sponsor: National Institutes of Health (NIH)
    Title: HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain - (U44 Clinical Trial Not Allowed) [RFA-NS-19-020]
    Award: $8,250,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-020.html
    NIDCR) is interested in preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat painful disorders of the orofacial region including temporomandibular joint disorders, trigeminal neuropathies, burning mouth syndrome, oral cancer pain, dental pain, and other conditions.

Submit by June 5, 2019: NIH

    Title: Biology of Bladder Cancer (R01 Clinical Trial Optional) [PAR-19-168]
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed project. [standard]
    Link: https://grants.nih.gov/grants/guide/pa-files/PAR-19-168.html
    This FOA encourages applications investigating the biology and underlying mechanisms of bladder cancer. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.

    Title: Biology of Bladder Cancer (R01 Clinical Trial Optional) [PAR-19-183]
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed project [standard]
    Link: http://grants.nih.gov/grants/guide/pa-files/PAR-19-183.html
    This FOA encourages applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.

    Title: Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) [PAR-19-193]
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed project [standard]
    Link: https://grants.nih.gov/grants/guide/pa-files/PAR-19-193.html
    This FOA is to stimulate the development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. Utilizing bacteria, archaebacteria, bacteriophages and other non-virus microorganisms, this initiative will support research projects designed to study the underlying mechanisms of the complex interactions between microorganisms, tumor, and immune system. The FOA also aims to support research into the use of microorganisms as delivery vehicles for cancer treatment and to complement or synergize with current therapies. This FOA will accept basic mechanistic and preclinical studies in cell culture and animal models in accordance with the state of the science. Applicants applying to this FOA are encouraged to address both the microbial and the tumor aspects of microbial-based cancer therapy.

    Title: Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) [PAR-19-200]
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed project [standard].
    Link: https://grants.nih.gov/grants/guide/pa-files/PA-19-200.html

Submit by June 10, 2019 to NIH

    Title: Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) [PAR-19-198]
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed project [standard]
    Link: https://grants.nih.gov/grants/guide/pa-files/PAR-19-198.html
    This FOA supports research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.

    Title: Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) [PAR-19-199]
    Award: $275,000
    Link: https://grants.nih.gov/grants/guide/pa-files/par-19-199.html
    This FOA supports research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.

Submit by June 16, 2019: NIH

    Title: Biology of Bladder Cancer (R21 Clinical Trial Optional) [PA-19-169]
    Award: $275,000
    Link: https://grants.nih.gov/grants/guide/pa-files/PAR-19-169.html
    Seeks applications investigating the biology and underlying mechanisms of bladder cancer. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.

    Title: Biology of Bladder Cancer (R21 Clinical Trial Optional) [PAR-19-184]
    Award: $275,000
    Link: https://grants.nih.gov/grants/guide/pa-files/PAR-19-184.html
    This FOA seeks applications investigating the biology and underlying mechanisms of bladder cancer. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.

    Title: Microbial-based Cancer Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) [PAR-19-194]
    Award: $275,000
    Link: https://grants.nih.gov/grants/guide/pa-files/par-19-194.html
    This FOA is to stimulate exploratory development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. Utilizing bacteria, archaebacteria, bacteriophages and other non-virus microorganisms, this initiative will support research projects designed to study the underlying mechanisms of the complex interactions between microorganisms, tumor, and immune system. The FOA also aims to support research into the use of microorganisms for cancer treatment and to complement or synergize with current therapies.

    Title: Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) [PAR-19-201]
    Award: $275,000
    Link: https://grants.nih.gov/grants/guide/pa-files/PA-19-201.html
    A limited body of research suggests that sleep disturbances, primarily insomnia, can increase cancer patients’ sensitivity to pain. NCI is interested in the broad topics (both pre-clinical and clinical) listed in this FOA within the context of cancer, and with a particular interest in the following cancer-specific pain conditions: Chemotherapy-induced peripheral neuropathy; Aromatase inhibitor arthralgias; Metastatic bone pain; Radiation-induced pain syndromes. In addition, NCI is interested in the population of patients undergoing curative therapies, particularly those receiving neurotoxic agents and/or undergoing radiation therapy, and how these therapies impact the onset and duration of sleep disturbances and subsequent development of treatment-induced pain conditions.

Submit by June 19, 2019

    Sponsor: NIH
    Title: Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20) [RFA-CA-19-034]
    Award: $2,400,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-034.html
    The P20 grants will support feasibility and planning activities to build comprehensive cancer health disparities research programs. All applications must propose translational research that will contribute to improved prevention, early detection, diagnosis, and/or treatment of cancers found to disproportionately affect specific racial/ethnic minority populations. Furthermore, all research projects must be focused upon knowledge of human biology with a translational human endpoint proposed.

Submit by July 1, 2019: SWOG/Hope Foundation

    Title: Impact Award 2019
    Award: $250,000
    Link: https://thehopefoundation.org/research-funding/juried-programs/swog-hope-foundation-impact-award/
    Encourages novel and innovative SWOG research by supporting early and conceptual stages of these projects. The work proposed should use resources from completed SWOG trials or be directly translatable to clinical trials in SWOG and the NCTN in the foreseeable future. Funding for smaller feasibility projects that are critical to the conduct of future SWOG trials are also encouraged.

Submit by July 19, 2019

    Sponsor: NIH
    Title: Tobacco Regulatory Science (R01 Clinical Trial Optional) [RFA-OD-19-091]
    Award: $900,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-019.html
    Invited: R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP).

Submit by August 1, 2019: NIH

    Title: Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) [RFA-CA-19-032]
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed R01 project. [standard]
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-032.html
    Provocative Questions in Cancer with an Underlying HIV Infection involves a set of 6 PQs. Each research project proposed in response to this FOA must be focused on addressing one particular research problem defined by one specific PQ selected from the list. Projects proposed to address specific PQs may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the scientific focus of the specific PQ chosen.

External funding opportunities are broken down by the month in which they are due


View All | Close

March, 2019

Submit by March 22, 2019 to NIH

Submit by March 22, 2019

Submit by March 26, 2019

LIMITED SUBMISSION

Submit by March 29, 2019

LIMITED SUBMISSION
April, 2019

Submit by April 1, 2019 to the American Cancer Society

Submit by April 1, 2019

Submit by April 4, 2019 to the ROGEL CANCER CENTER

Submit by April 8, 2019 to the National Institutes of Health (NIH)

Submit by April 23, 2019 to the Department of Defense (DoD)

Submit by April 25, 2019

Submit by April 30, 2019 to the DoD

Submit by April 30, 2019

May, 2019

Submit by May 1, 2019 to the ROGEL CANCER CENTER

    Title: Breast Oncology RFA for Lobular Breast Cancer and Other Areas of Breast Cancer Research
    Award: $100,000
    Link: https://umms.infoready4.com/#competitionDetail/1785500
    Studies can be laboratory, translational, or clinical studies, but must be focused on one of these topics: 1) The biology or clinical behavior, evaluation, and/or treatment of lobular breast cancer; 2) The function and/or clinical impact of genes associated with hereditary breast cancer in special underserved populations in cancer genetics, including but not restricted to: African Americans, LatinX, Africans, and south east Asians (Indian sub-continent and island states). If you include a different population, you must make the case that they are underserved in clinical cancer genetics; 3) Other areas specifically related cause, biology, evaluation, or treatment of breast cancer.

Submit by: May 23, 2019

Limited Submission

Submit by: May 25, 2019

    Sponsor: National Institutes of Health (NIH)
    Title: Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]
    (RFA-OD-19-011)

June, 2019

Submit by June 4, 2019

    Sponsor: National Institutes of Health (NIH)
    Title: HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain - (U44 Clinical Trial Not Allowed) [RFA-NS-19-020]
    Award: $8,250,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-020.html
    NIDCR) is interested in preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat painful disorders of the orofacial region including temporomandibular joint disorders, trigeminal neuropathies, burning mouth syndrome, oral cancer pain, dental pain, and other conditions.

Submit by June 5, 2019 to NIH

Submit by June 10, 2019 to the NIH

Submit by June 16, 2019 to NIH

Submit by June 19, 2019

July, 2019

Submit by: July 1, 2019

Submit by July 19, 2019

August, 2019

Submit by August 1, 2019

    Sponsor: National Institutes of Health (NIH)
    Title: Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) [RFA-CA-19-032]
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed R01 project. [standard]
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-032.html

September, 2019

None at this time.

October, 2019

None at this time.

November, 2019

None at this time.

December, 2019

No opportunities at this time.

January, 2020

None at this time.

February, 2020

No opportunities at this time.


Additional Funding Sources:

back to top